Vera Constâncio Selected Research

Biomarkers (Surrogate Marker)

1/2023	DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation.
1/2023	MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?
6/2022	One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer.
2/2022	LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma.
10/2021	Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma.
9/2021	Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes.
6/2021	Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer.
3/2021	Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances.
10/2020	Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
1/2020	DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vera Constâncio Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 02/2022 - 09/2021
3	Carcinogenesis 02/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 06/2021 - 10/2020
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022
1	Kidney Neoplasms (Kidney Cancer) 03/2021
1	Urologic Neoplasms (Urological Cancer) 03/2021
1	Testicular Germ Cell Tumor 01/2021
1	Embryonal Carcinoma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
8	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2019
4	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2019
2	AndrogensIBA 11/2020 - 01/2019
1	Cadherins (E-Cadherin)IBA 02/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	R-cadherinIBA 02/2022
1	6-methyladenineIBA 09/2021
1	N-methyladenosineIBA 09/2021
1	RNA (Ribonucleic Acid)IBA 09/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Epidermal Growth Factor (EGF)IBA 12/2020
1	Trastuzumab (Herceptin)FDA Link 12/2020
1	Hormones (Hormone)IBA 11/2020
1	Androgen Receptors (Androgen Receptor)IBA 11/2020
1	Serine (L-Serine)FDA Link 11/2020
1	CytokinesIBA 11/2020
1	A-Form DNA (A-DNA)IBA 12/2019
1	ProstaglandinsIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	CollagenIBA 01/2019
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019

Therapy/Procedure

1	Neoadjuvant Therapy 01/2023
1	Therapeutics 01/2021
1	Intravenous Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2021